Clinical Trials Directory

Trials / Completed

CompletedNCT04342065

Pregabalin Versus Celecoxib on Sevoflurane and Analgesic Consumption in Spine Fixation Surgery

Efficacy of Pre-emptive Different Doses of Oral Pregabalin Versus Celecoxib on Sevoflurane and Analgesic Consumption in Patients Subjected for Elective Lumbar Spine Fixation Surgery: a Randomized Controlled Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
200 (actual)
Sponsor
South Egypt Cancer Institute · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The anti-epileptic drugs such as gabapentin and other non-steroidal anti-inflammatory drugs (NSAID) such as celecoxib were used as a part of multimodal analgesia to control such pain. Gabapentin is an anticonvulsant drug that has analgesic effect in post-herpetic neuralgia, diabetic neuropathy, and neuropathic pain. Celecoxib is one of the NSAIDs, that its analgesic effect is reported in various studies by cyclooxygenase-2 (COX-2) inhibitor. The aim of this randomized double-blinded study was to asses and compare the efficacy of using gabapentin versus celecoxib as a part of multimodal analgesia in perioperative hemodynamic control and pain relief in patients underwent posterior approach lumbar spine disc fixation surgery.

Conditions

Interventions

TypeNameDescription
DRUGCelecoxib capsulesreceived celecoxib 200 mg 2 hours preoperative and the same dose 6 hours postoperative.
DRUGPregabalin 150mgreceived Pregabalin 150mg 2 hours preoperative and the same dose 6 hours postoperative.

Timeline

Start date
2019-01-01
Primary completion
2020-01-30
Completion
2020-02-01
First posted
2020-04-10
Last updated
2020-04-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04342065. Inclusion in this directory is not an endorsement.